Overexpression of SH2-containing Inositol Phosphatase 2 Results in Negative Regulation of Insulin-induced Metabolic Actions in 3T3-L1 Adipocytes Via Its 5'-phosphatase Catalytic Activity
Overview
Authors
Affiliations
Phosphatidylinositol (PI) 3-kinase plays an important role in various metabolic actions of insulin including glucose uptake and glycogen synthesis. Although PI 3-kinase primarily functions as a lipid kinase which preferentially phosphorylates the D-3 position of phospholipids, the effect of hydrolysis of the key PI 3-kinase product PI 3,4,5-triphosphate [PI(3,4,5)P3] on these biological responses is unknown. We recently cloned rat SH2-containing inositol phosphatase 2 (SHIP2) cDNA which possesses the 5'-phosphatase activity to hydrolyze PI(3,4,5)P3 to PI 3,4-bisphosphate [PI(3,4)P2] and which is mainly expressed in the target tissues of insulin. To study the role of SHIP2 in insulin signaling, wild-type SHIP2 (WT-SHIP2) and 5'-phosphatase-defective SHIP2 (Delta IP-SHIP2) were overexpressed in 3T3-L1 adipocytes by means of adenovirus-mediated gene transfer. Early events of insulin signaling including insulin-induced tyrosine phosphorylation of the insulin receptor beta subunit and IRS-1, IRS-1 association with the p85 subunit, and PI 3-kinase activity were not affected by expression of either WT-SHIP2 or Delta IP-SHIP2. Because WT-SHIP2 possesses the 5'-phosphatase catalytic region, its overexpression marked by decreased insulin-induced PI(3,4,5)P3 production, as expected. In contrast, the amount of PI(3,4,5)P3 was increased by the expression of Delta IP-SHIP2, indicating that Delta IP-SHIP2 functions in a dominant-negative manner in 3T3-L1 adipocytes. Both PI(3,4,5)P3 and PI(3,4)P2 were known to possibly activate downstream targets Akt and protein kinase C lambda in vitro. Importantly, expression of WT-SHIP2 inhibited insulin-induced activation of Akt and protein kinase C lambda, whereas these activations were increased by expression of Delta IP-SHIP2 in vivo. Consistent with the regulation of downstream molecules of PI 3-kinase, insulin-induced 2-deoxyglucose uptake and Glut4 translocation were decreased by expression of WT-SHIP2 and increased by expression of Delta IP-SHIP2. In addition, insulin-induced phosphorylation of GSK-3beta and activation of PP1 followed by activation of glycogen synthase and glycogen synthesis were decreased by expression of WT-SHIP2 and increased by the expression of Delta IP-SHIP2. These results indicate that SHIP2 negatively regulates metabolic signaling of insulin via the 5'-phosphatase activity and that PI(3,4,5)P3 rather than PI(3,4)P2 is important for in vivo regulation of insulin-induced activation of downstream molecules of PI 3-kinase leading to glucose uptake and glycogen synthesis.
Insulin signaling in development.
Suzawa M, Bland M Development. 2023; 150(20).
PMID: 37847145 PMC: 10617623. DOI: 10.1242/dev.201599.
Wada T, Miyazawa Y, Ikurumi M, Fuse K, Okekawa A, Onogi Y Nutr Metab (Lond). 2023; 20(1):10.
PMID: 36774476 PMC: 9921322. DOI: 10.1186/s12986-023-00732-5.
Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured Myotubes.
Berg M, Naams J, Hautala L, Tolvanen T, Ahonen J, Lehtonen S ACS Omega. 2020; 5(3):1430-1438.
PMID: 32010815 PMC: 6990439. DOI: 10.1021/acsomega.9b02944.
Su K, Yu Y Cancers (Basel). 2019; 11(8).
PMID: 31357665 PMC: 6721294. DOI: 10.3390/cancers11081065.
SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.
Lehtonen S Acta Physiol (Oxf). 2019; 228(1):e13349.
PMID: 31342643 PMC: 6916339. DOI: 10.1111/apha.13349.